You are absolutely spot on with that--it will take something very significant to make this pps move. The damage has been done in that this stock doesn't have the ability to do anything on potential anymore. Rather, it will require significant news of FDA approval or BP's or similar's backing before we see any momentum. Pity that is. But, it is what it is. Or so it seems to be based on the fact that those bloody walls just keep appearing and the games are continuously played at everyone else's expense.
Who knows...maybe when all that Fire Engine Red lipstick is applied to the company image more venture capitalists will take notice and jump in. I mean, with the patents present, the treatments in the pipeline and the revenue potential of this company, who wouldn't want a piece of this pie?
You best believe with Regen/Bio-Matrix being featured in five Market Research publications for 2013 alone and the number of times Dr. Ichim's publications are referenced, they are on radars.